New Mountain Vantage Advisers L.l.c. buys $116,012,975 stake in McKesson Corporation (MCK)

McKesson Corporation (MCK) : New Mountain Vantage Advisers L.l.c. scooped up 146,080 additional shares in McKesson Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 594,207 shares of McKesson Corporation which is valued at $116,012,975.McKesson Corporation makes up approximately 6.40% of New Mountain Vantage Advisers L.l.c.’s portfolio.

Other Hedge Funds, Including , Wellington Shields added MCK to its portfolio by purchasing 1,080 company shares during the most recent quarter which is valued at $210,859. McKesson Corporation makes up approx 0.12% of Wellington Shields’s portfolio.Scharf Investments reduced its stake in MCK by selling 53,646 shares or 4.51% in the most recent quarter. The Hedge Fund company now holds 1,136,370 shares of MCK which is valued at $221,864,879. McKesson Corporation makes up approx 4.69% of Scharf Investments’s portfolio.Thompson Siegel Walmsley boosted its stake in MCK in the latest quarter, The investment management firm added 5,816 additional shares and now holds a total of 6,650 shares of McKesson Corporation which is valued at $1,294,489. McKesson Corporation makes up approx 0.02% of Thompson Siegel Walmsley’s portfolio.Sawgrass Asset Management reduced its stake in MCK by selling 1,420 shares or 0.69% in the most recent quarter. The Hedge Fund company now holds 203,709 shares of MCK which is valued at $39,751,774. McKesson Corporation makes up approx 1.81% of Sawgrass Asset Management’s portfolio.Nippon Life Insurance Co reduced its stake in MCK by selling 1,706 shares or 14.2% in the most recent quarter. The Hedge Fund company now holds 10,311 shares of MCK which is valued at $2,012,089. McKesson Corporation makes up approx 0.05% of Nippon Life Insurance Co’s portfolio.

McKesson Corporation closed down -1.35 points or -0.73% at $183.27 with 7,96,655 shares getting traded on Thursday. Post opening the session at $184.72, the shares hit an intraday low of $182.13 and an intraday high of $184.72 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, McKesson Corporation reported $3.50 EPS for the quarter, beating the analyst consensus estimate by $ 0.16 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $3.34. The company had revenue of $49733.00 million for the quarter, compared to analysts expectations of $50333.03 million. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 EPS.

Many Wall Street Analysts have commented on McKesson Corporation. Company shares were Reiterated by Mizuho on Aug 11, 2016 to “Neutral”, Firm has raised the Price Target to $ 197 from a previous price target of $174 .Company shares were Reiterated by Mizuho on Jun 7, 2016 to “Neutral”, Firm has raised the Price Target to $ 174 from a previous price target of $164 .McKesson Corporation was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers and practice management technology clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical patient care financial supply chain and strategic management software solutions as well as connectivity outsourcing and other services including remote hosting and managed services to healthcare organizations.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *